TITLE

Product Recall, Flu Season Impact Perrigo Results

AUTHOR(S)
Emrich, Anne Bond
PUB. DATE
February 2005
SOURCE
Grand Rapids Business Journal;2/7/2005, Vol. 23 Issue 6, p6
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses the financial performance of Perrigo Co. of Allegan, Michigan for the second quarter of fiscal 2005. Increase in net sales; Effect of the company's retail level recall of loratadine syrup on sales; Growth in the core vitamin product category of the company.
ACCESSION #
16108796

 

Related Articles

  • Perrigo income tops charts at $90 million. Slowik, Elizabeth // Grand Rapids Business Journal;2/7/2011, Vol. 29 Issue 6, p5 

    The article highlights the record quarterly revenue and earnings posted by Allegan, Michigan-based health and generic drug business Perrigo Co. in the first half of 2011.

  • Horizon Pharma's Q1 Mixed. Investor's Business Daily // Investors Business Daily;5/11/2015, pA01 

    4 The specialty drugmaker's EPS rose 62% to 21 cents, matching views. Sales jumped 118% to $113.1 mil, $9 mil above estimates.

  • Teva Will Buy Allergan Generics. Investor's Business Daily // Investors Business Daily;8/3/2015, pB02 

    8 The Israeli generics drug giant will pay $40.5 bil for the huge

  • Perrigo Company SWOT Analysis.  // Perrigo Company SWOT Analysis;Jun2014, p1 

    A SWOT analysis of Perrigo Co. PLC is presented.

  • Perrigo Co's (Allegan MI) fiscal second-quarter earnings climbed 11%, as revenue for the maker of infant formula and store-brand drugs rose due to new products and an acquisition.  // MondayMorning;2/13/2012, Vol. 20 Issue 7, p1 

    The article discusses financial performance of Allegan, Michigan-based firm Perrigo Co. It has been informed that second-quarter earnings of the firm increased 11% due to new products and acquisition of generic drugmaker Paddock Laboratories. It has been informed that Perrigo earned 99.7 million...

  • Perrigo Company Awarded A Good Manufacturing Seal. Czurak, David // Grand Rapids Business Journal;4/22/2002, Vol. 20 Issue 16, pB8 

    Reports on The National Sanitary Foundation (NSF) International's awarding of its first Good Manufacturing Practices (GMP) registration to pharmaceuticals, vitamins and nutritional supplements manufacturer Perrigo Co. Functions of NSF; Role of the NSF GMP in validating the standards of a...

  • Perrigo rejects new Mylan bid. Investor's Business Daily // Investors Business Daily;4/30/2015, pA02 

    The article reports that drugstore supplier Perrigo Co. PLC has rejected the bid offered by American generic-drug maker Mylan NV following speculations that the bid would be bought by pharmaceutical company Teva Pharmaceutical Industries Ltd.

  • Mylan Says Can Close Perrigo Deal by Year End; Reports Profit.  // MondayMorning;5/11/2015, Vol. 23 Issue 19, p1 

    The article reports on the planned acquisition of pharmaceuticals company Perrigo Co. Plc by pharmaceutical firm Mylan NV by the end of 2015. Information regarding Mylan NV's business takeover to Teva Pharmaceutical Industries Ltd., its financial performance including its quarterly profit,...

  • Prestige accelerates growth. Investor's Business Daily // Investors Business Daily;2/6/2015, pA02 

    The article reports on the financial performance of American over-the-counter (OTC) medical products manufacturers Prestige Brands Holdings Inc. (PBH) and Perrigo Co PLC. Among the key indicators of the performance include the earnings per share (EPS), market shares, and OTC sales. It revealed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics